Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CTNMCTNM
9 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in CONTINEUM THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 214,082 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $3.5M as of 2026-Q2. The position was increased (+48.7% shares). CTNM represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$3.5M

Current Shares

214,082

Total Value Change

+$2.6M

Total Shares Change

+162,310

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
214,082
+48.7%
$3.5M0.0%$16.39
37
2026-Q1
Increased
144,009
+30.8%
$1.9M0.0%$14.10
33
2025-Q4
Decreased
110,061
-0.1%
$1.3M0.0%$11.40
0
2025-Q3
Increased
110,178
+323.1%
$1.3M0.0%$11.82
41
2025-Q2
Decreased
26,039
-49.1%
$103,3750.0%$4.11
0
2025-Q1
Decreased
51,202
-7.5%
$357,3900.0%$7.07
0
2024-Q4
Increased
55,330
+27.8%
$810,5850.0%$14.47
31
2024-Q3
Decreased
43,295
-16.4%
$828,6660.0%$18.84
0
2024-Q2
New
51,772
-
$911,7050.0%$17.61
34

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used